|
2024
|
P/S
|
Molecular antigens to induce the formation of antibodies in a cell for use in immunological resea... |
|
|
P/S
|
Molecular antigens to induce the formation of antibodies in a cell for use in immunology research... |
|
|
P/S
|
Molecular antigens to induce the formation of antibodies in
a cell for use in immunological rese... |
|
|
Invention
|
Methods of isolating poxviruses from avian cell cultures. The present invention relates to method... |
|
|
Invention
|
Production of poxviruses from quail cell cultures. The present invention relates to methods of pr... |
|
|
Invention
|
Use of quail cell lines for poxvirus production. The present invention relates to methods of cult... |
|
|
Invention
|
Recombinant modified sarna (vrp) for cancer vaccine. The present invention provides self-amplifyi... |
|
2023
|
Invention
|
Virus-like particles displaying sars-cov-2 antigens as booster vaccines and uses thereof. The pre... |
|
|
P/S
|
Pharmaceutical products and preparations for the treatment and prevention of diseases caused by p... |
|
|
P/S
|
Pharmaceutical products and/or preparations for the treatment of and/or prevention of diseases ca... |
|
|
Invention
|
Mammalian cell line for the production of modified vaccinia virus ankara (mva). The present inven... |
|
|
Invention
|
Epstein-barr-virus vaccine. The present invention relates to vaccines based on a viral vector for... |
|
|
Invention
|
Recombinant modified sarna (vrp) and vaccinia virus ankara (mva) prime-boost regimen. The present... |
|
|
P/S
|
Pharmaceutical preparations and compositions, including vaccine for prophylactic use and for the ... |
|
|
P/S
|
Pharmaceutical preparations and compositions, including
vaccine for prophylactic use and for the... |
|
|
P/S
|
Virus-based pharmaceutical preparations for human medical and veterinary purposes, namely, vaccin... |
|
2022
|
Invention
|
Therapy for modulating immune response with recombinant mva encoding il-12. The invention relates... |
|
|
Invention
|
Recombinant mva viruses for intraperitoneal administration for treating cancer. The invention rel... |
|
|
Invention
|
Utilization of micro-rna for downregulation of cytotoxic transgene expression by modified vaccini... |
|
|
P/S
|
Pharmaceutical preparations and compositions, namely, vaccines for human use, vaccines for human ... |
|
|
P/S
|
Pharmaceutical preparations and compositions, namely, vaccines for prophylactic use and the treat... |
|
|
P/S
|
Pharmaceutical preparations and compositions, including
vaccines for prophylactic use and the tr... |
|
|
P/S
|
Pharmaceutical preparations, namely, chikungunya virus VLP vaccines |
|
|
P/S
|
Pharmaceutical preparations, namely, Chikungunya virus VLP vaccines. |
|
|
P/S
|
Pharmaceutical preparations, namely, Chikungunya virus VLP vaccines |
|
|
Invention
|
Vaccines comprising virus-like particles displaying sars-cov-2 antigens and methods of use. The i... |
|
|
Invention
|
Combination therapy for treating cancer with an antibody and intravenous administration of a reco... |
|
2021
|
Invention
|
Poxvirus vectors encoding hiv antigens, and methods of use thereof. Poxvirus vectors encoding a s... |
|
|
P/S
|
pharmaceutical preparations, namely, Chikungunya virus VLP vaccines |
|
|
Invention
|
Methods and compositions for inducing protective immunity against filovirus infection. The presen... |
|
|
Invention
|
Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine.
Th... |
|
|
Invention
|
Compositions and methods for enhancing the stability of transgenes in poxviruses. Provided herein... |
|
|
Invention
|
A recombinant modified vaccinia virus (mva) vaccine against coronavirus disease.
The invention r... |
|
|
Invention
|
A recombinant modified vaccinia virus ankara (mva) vaccine against coronavirus disease. The inven... |
|
|
Invention
|
Methods and compositions for inducing an immune response against hepatitis b virus (hbv).
Provid... |
|
|
Invention
|
Methods and compositions for enhancing vaccine immune responses.
Provided herein are immunogenic... |
|
|
Invention
|
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagon... |
|
|
Invention
|
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine.
Prov... |
|
|
Invention
|
Conditions improving poxvirus stability.
The present invention relates to aqueous compositions c... |
|
|
Invention
|
Compositions improving poxvirus stability. The present invention relates to aqueous compositions ... |
|
|
P/S
|
Vaccines; Adjuvants for use with vaccines; Pharmaceutical preparations for the prevention of Tick... |
|
|
Invention
|
Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine. The present i... |
|
2020
|
Invention
|
Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer.
... |
|
|
Invention
|
Medical uses of 4-1bbl adjuvanted recombinant modified vaccinia virus ankara (mva).
The inventio... |
|
|
Invention
|
Medical uses of 4-1bbl adjuvanted recombinant modified vaccinia virus ankara (mva). The invention... |
|
|
Invention
|
Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer. T... |
|
|
Invention
|
Chikungunya virus-like particle vaccine and methods of using the same.
The present disclosure is... |
|
|
Invention
|
Chikungunya virus-like particle vaccine and methods of using the same. The present disclosure is ... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for the treatment of rabies; vaccines for human use an... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for the treatment of rabies; vaccines and adjuvants fo... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; vaccines and
adjuvants for use with vaccines. |
|
|
Invention
|
Compositions and methods for inducing an enhanced immune response using poxvirus vectors.
Provid... |
|
|
P/S
|
Laboratory chemicals, namely, molecular antigens reagents to induce the formation of antibodies i... |
|
|
P/S
|
Molecular antigens to induce the formation of antibodies in
a cell for use in immunology researc... |
|
|
Invention
|
Multivalent recombinant modified vaccinia virus ankara (mva) vector encoding filovirus immunogens... |
|
|
Invention
|
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine. Provi... |
|
2019
|
Invention
|
Therapy for treating cancer with an intratumoral or intravenous administration of a recombinant m... |
|
|
Invention
|
Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombina... |
|
|
Invention
|
Combination therapy for treating cancer with an intravenous administration of a recombinant mva a... |
|
|
Invention
|
Storage improved poxvirus compositions. The present invention provides storage optimized aqueous ... |
|
|
P/S
|
Bio-chemical substances for analyses in laboratories, other than for medical or veterinary purpos... |
|
2018
|
Invention
|
Stable virus-containing composition. Described herein are compositions and pharmaceutical composi... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations
for prevention and treatment of infecti... |
|
|
P/S
|
Vaccines for human use. |
|
|
Invention
|
Mva-bn and ad26.zebov or ad26.filo prime-boost regimen. Compositions and methods are described fo... |
|
2016
|
P/S
|
Preparations for the treatment and prevention of cancer; vaccines; vaccines against tumor disease... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; preparations for
the treatment and prevention of can... |
|
|
P/S
|
Vaccines. |
|
2015
|
P/S
|
Pharmaceutical preparations, namely, serums and vaccines for the prevention of typhoid fever |
